Role of endothelin-1 in tamoxifen resistance: Mechanism for a new possible treatment strategy in breast cancer

Medical Hypotheses

Volumn 70, Issue 1, 2008, Pages 109-111

  Namazi, Soha ^a   Rouhani Fard, Shirin Ardeshir ^a   Abedtash, Hamed ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; ESTROGEN; ESTROGEN RECEPTOR; TAMOXIFEN;

ANGIOGENESIS; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER RESISTANCE; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; DRUG PROTEIN BINDING; ESTROGEN BLOOD LEVEL; FIBROBLAST; HEART PROTECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MITOGENESIS; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; RISK FACTOR; VASOCONSTRICTION;

ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; DRUG RESISTANCE, NEOPLASM; ENDOTHELIN-1; FEMALE; HUMANS; TAMOXIFEN;

EID: 36349035945     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2007.01.092     Document Type: Article

References (17)

1. Singh R.R., and Kumar R. Steroid hormone receptor signaling in tumorigenesis. J Cell Biol 96 (2005) 490-505
2. Wülfing P., Diallo R., Kersting C., et al. Expression of endothelin-1, endothelin-A, and endothelin-B receptor in human breast cancer and correlation with long-term follow-up. Clin Cancer Res 9 (2003) 4125-4131
3. Dubey R.K., Jackson E.K., Keller P.J., Imthurn B., and Rosselli M. Estradiol metabolites inhibit endothelin synthesis by an estrogen receptor-independent mechanism. Hypertension 37 pt 2 (2001) 640-644
4. Deroo B.J., and Korach K.S. Estrogen receptors and human disease. J Clin Invest 116 (2006) 561-570
5. Bagnato A., and Natali P.G. Endothelin receptors as novel targets in tumor therapy. J Transl Med 2 (2004) 16
6. Grimshaw M.J. Endothelins in breast tumor cell invasion. Cancer Lett 222 (2005) 129-138
7. Zivadinovic D., and Watson C.S. Membrane estrogen receptor-α levels predict estrogen-induced ERK1/2 activation in MCF-7 cells. Breast Cancer Res 7 (2005) R130-R144
8. Nuedling S., Eickels M.V., Alléra A., et al. 17β-Estradiol regulates the expression of endothelin receptor type B in the heart. Br J Pharmacol 140 (2003) 195-201
9. Webb C.M., Ghatei M.A., McNeill J.G., and Collins P. 17ß-Estradiol decreases endothelin-1 levels in the coronary circulation of postmenopausal women with coronary artery disease. Circulation 102 (2000) 1617-1622
10. Ali S.H., O'Donnell A.L., Balu D., et al. High levels of oestrogen receptor-α in tumorigenesis: inhibition of cell growth and angiogenic factors. Cell Prolif 34 (2001) 223-231
11. Ali S.H., O'Donnell A.L., Mohamed S., Mousa S., and Dandona P. Stable over-expression of estrogen receptor-α in ECV304 cells inhibits proliferation and levels of secreted endothelin-1 and vascular endothelial growth factor. Mol Cell Endocrinol 152 (1999) 1-9
12. Tan Z., Wang T.H., Yang D., Fu X.D., and Pan J.Y. Mechanisms of 17β-estradiol on the production of ET-1 in ovariectomized rats. Life Sci 73 (2003) 2665-2674
13. Rodrigo M.C., Martin D.S., and Eyster K.M. Vascular ECE-1 mRNA expression decreases in response to estrogens. Life Sci 73 (2003) 2973-2983
14. Hutchison S.J., Chou T.M., Chatterjee K., and Sudhir K. Tamoxifen is an acute, estrogen-like, coronary vasodilator of porcine coronary arteries in vitro. J Cardiovasc Pharmacol 38 5 (2001) 657-665
15. Milano A., Lago L.D., Sotiriou C., Piccart M., and Cardoso F. What clinicians need to know about antioestrogen resistance in breast cancer therapy. Eur J Cancer 42 (2006) 2692-2705
16. Marttunen M.B., Hietanen P., Tiitinen A., Viinikka L., and Ylikorkala O. Antiestrogens reduce plasma levels of endothelin-1 without affecting nitrate levels in breast cancer patients. Gynecol Endocrinol 14 1 (2000) 55-59
17. Pearson G., Robinson F., Gibson T.B., et al. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 22 2 (2001) 153-183